glp-1 drugs glycemic control mechanism Mechanisms by which agonists may exert beneficial effects on the Glucagon‐like peptide‐1 receptor agonist (GLP‐1RA)
Description
Promising clinical trial data suggests big opportunity with Eli Lilly's retatrutide GLP-1 candidate.
Read more: #clinicaltrials #clinicalresearch #cvd #glp1
In a trial, people lost 75% fat and 25% muscle.
GLP-1 not working
Discover what GLP-1 is, how it works, and why it is the foundation of todays most powerful weight loss medications.
